Aptuit | Translation biomarkers

Translational Biomarkers

Transforming Drug Discovery and Development

Aptuit is transforming the Drug Discovery and Development process by advancing genomics, proteomics and systems biology while growing our understanding of the molecular underpinnings of disease. We are carrying out translational or “bench-to-bedside” research that is expediting the translation of these scientific discoveries into clinical practice.Aptuit | Translational biomarkers

Predictive biomarkers that enable the go/no go selection of lead compounds for development include markers of efficacy, response and safety, constituting unprecedented pharmacodynamic indicators of drug activity and toxicity for subsequent use in clinical development to deliver valuable candidates with high probability of success.

Our multi-disciplinary approach is essential to streamlining the interpretation of data generated from biomarker analysis in complex integrated studies.